Comparison of Two Biphasic Insulin Regimens in Well-controlled Patients With the Use of Continuous Glucose Monitoring and New Glycemic Control Indices
A cross-over study of 36 well controlled people with type 2 Diabetes Mellitus who underwent 7-day Continuous Glucose Monitoring with Premixed Human Insulin 30/70 and subsequently with Biphasic Aspart 30.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
36
premixed human insulin
Premixed Insulin Analog Biphasic Aspart 30
Change in average blood glucose
average blood glucose (mg/dl) from continuous glucose monitoring
Time frame: 7 days
Glycated Albumin
levels of glycated albumin (%) in serum
Time frame: 7 days
Fructosamine
levels of fructosamine (μmol/L) in serum
Time frame: 7 days
Daily Insulin requirements
change in total daily dose of insulin (u)
Time frame: 7 days
nocturnal average blood glucose
change in nocturnal average blood glucose
Time frame: 7 days
Time in range
change in time in range (% and minutes) from continuous glucose monitoring
Time frame: 7 days
time above 180
change in time above 180 (% and minutes) from continuous glucose monitoring
Time frame: 7 days
time below 70
change in time below 70 (% and minutes) from continuous glucose monitoring
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.